Founded 2017 by Alltech. Three-month agritech accelerator focused on nutrition, animal health, robotics, and AI; provides access to Alltech's global network, mentoring, and pilot opportunities on farms.
Scope: International.
Dublin, Ireland
Accelerator
/ireland/accelerator/the-pearse-lyons-accelerator
smaXtec builds ingestible sensor and AI monitoring systems for dairy cows to detect health issues early and improve herd management decisions, competing with precision livestock platforms such as Allflex, CowManager, and Nedap.
11x is the breakout star of the UK's agentic AI wave, known for building "digital workers" that replace full job functions rather than merely assisting them. Founded in 2022 by Hasan Sukkar, the company frames its product as autonomous employees rather than software tools. That positioning is controversial, but it resonates with revenue teams seeking to eliminate manual drudgery and scale outreach without linear headcount growth. The flagship product, Alice, is an AI Sales Development Representative that can source leads, research accounts, craft highly personalized outreach, and follow up continuously. In late 2024, 11x launched Jordan, a multilingual AI phone agent that conducts real-time voice conversations for qualification and support in more than 30 languages. Together, these agents can run a large portion of the outbound funnel end-to-end, from initial outreach to handoff, with human oversight focused on high-value exceptions. By early 2026, 11x had exploded in valuation after a Series B led by Andreessen Horowitz, a rare win for a UK-first startup. The company processes millions of interactions for high-growth tech companies such as Otter.ai and Airwallex and is expanding its footprint in San Francisco to preempt US-based competitors. The roadmap centers on "digital teams" that coordinate multiple agents across tasks: one agent identifies a lead, another calls, a third negotiates logistics, and a final agent drafts the contract. This orchestration layer is the company's strategic bet on becoming the default system for revenue operations. The company's roots include Y Combinator's Summer 2023 batch, which accelerated its US network and credibility, and its UK engineering base sits in the London Bridge tech hub. Investor support spans US and European capital: a16z led the Series B, Benchmark led the Series A, Lux Capital participated early, Quiet Capital backed growth, and 20VC provided influential local support. In 2026, 11x is the UK's most visible play on AI-native revenue teams, aiming to become a category-defining platform for autonomous sales operations.
Bandora is an AI-powered virtual facility manager that integrates with existing building management systems to optimize energy efficiency, reduce costs, and maintain comfort in commercial buildings. The startup has reported about USD 1M-1.5M in pre-seed/seed backing and won the CTA CEO Summit startup pitch in Lisbon, earning a complimentary exhibit space at CES 2026 in Las Vegas.
Be My Eyes is a Danish accessibility platform that connects blind and low vision users with sighted volunteers and company support teams through live video calls. Founded in 2015 by Hans Jorgen Wiberg, the app created a global community of millions of volunteers who provide real time visual assistance. The company later added enterprise support partnerships and AI powered visual descriptions. Be My Eyes is a leading example of Danish tech for social impact.
Bioptimus is the self-proclaimed "Mistral of Biology," spun out in early 2024 by a team of alumni from Google DeepMind and Owkin, including CEO Jean-Philippe Vert. The company is building what it calls the first universal foundation model for biology. Where large language models were trained on text to learn human language, Bioptimus trains on biological data—DNA sequences, protein structures, cellular imagery, and clinical phenotypes—to infer the underlying rules of life. The ambition is not just better predictions but a unified biological reasoning layer that can simulate outcomes before expensive lab work happens. By 2026, Bioptimus has moved from a research thesis to early commercial traction. After a $41M Series A in 2025, the company released its first commercial model that can predict how a specific molecule will interact with a human cell with unusually high accuracy. This enables in-silico screening that reduces wet-lab costs and improves hit rates for drug discovery. French pharma leaders such as Sanofi have begun using these models to prioritize compounds and compress early-stage discovery timelines. The product value is immediate: fewer failed experiments, faster candidate selection, and deeper mechanistic insight. Bioptimus' roadmap focuses on "multi-scale biology," connecting the micro level (genomics and proteomics) to the macro level (patient outcomes and clinical data). Rather than being limited to protein folding, the models aim to bridge across data modalities so a genetic mutation can be linked to disease pathways, tissue behavior, and potential therapeutic interventions. This requires data breadth and regulatory trust, and Bioptimus is building a defensive moat through European data sovereignty. It leverages partnerships with European research hospitals and biobanks to access high-quality patient data that is difficult for US competitors to acquire under GDPR constraints. That compliance burden becomes a competitive advantage: safer access, better provenance, and stronger alignment with European health data governance. The company remains deeply embedded in the Paris ecosystem. It was incubated inside Owkin before spinning out, maintains a presence around Station F, and benefits from the cross-pollination between French AI and biotech communities. Its investor base reflects that positioning: Sofinnova Partners, Bpifrance, Cathay Innovation, Xavier Niel, and Frst provide a blend of life-science expertise, sovereign capital, and deep-tech conviction. In 2026, Bioptimus is the clearest European bet that foundation models can unlock biology at scale—and a contender to become the default AI layer for drug discovery in Europe.
Blockbrain builds private enterprise AI assistants that connect to internal knowledge tools such as Slack, Notion, Google Drive, and email. The platform creates context-aware internal search and answer workflows to reduce information fragmentation and speed up employee access to institutional knowledge.
Checking login status...
Loading comments...